Benjamin D.�L. Li
- Molecular Biology top 10%
- Oncology top 5%
- Cancer Research top 5%
- Endocrinology, Diabetes and Metabolism top 5%
- Immunology top 10%
- Co-authors
- Quyen D. ChuArrigo De BenedettiHerbert YuLester W. JohnsonCarol MeschonatFleurette AbreoHans J. BerkelRoger H. Kim
- Topics
- PI3K/AKT/mTOR signaling in cancer (19 papers)Chemokine receptors and signaling (10 papers)Immunotherapy and Immune Responses (9 papers)
- Partner nations
- United StatesChinaCzechia
In The Last Decade
Benjamin D.�L. Li
66 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 103
- Molecular Biology 1.0k
- Oncology 834
- Cancer Research 368
- Endocrinology, Diabetes and Metabolism 295
- Immunology 253
Countries citing papers authored by Benjamin D.�L. Li
This map shows the geographic impact of Benjamin D.�L. Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin D.�L. Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin D.�L. Li more than expected).
Fields of papers citing papers by Benjamin D.�L. Li
This network shows the impact of papers produced by Benjamin D.�L. Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin D.�L. Li. The network helps show where Benjamin D.�L. Li may publish in the future.
Co-authorship network of co-authors of Benjamin D.�L. Li
This figure shows the co-authorship network connecting the top 25 collaborators of Benjamin D.�L. Li. A scholar is included among the top collaborators of Benjamin D.�L. Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Benjamin D.�L. Li. Benjamin D.�L. Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 16 | |
| 2 | 15 | |
| 3 | 8 | |
| 4 | 48 | |
| 5 | 17 | |
| 6 | 12 | |
| 7 | 21 | |
| 8 | 26 | |
| 9 | 9 | |
| 10 | 23 | |
| 11 | 51 | |
| 12 | 2 | |
| 13 | 18 | |
| 14 | 27 | |
| 15 | 21 | |
| 16 | 65 | |
| 17 | 60 | |
| 18 | 31 | |
| 19 | 21 | |
| 20 | 4 |
About Benjamin D.�L. Li
Benjamin D.�L. Li is a scholar working on Oncology, Cancer Research and Immunology, having authored 67 papers that have together received 1.9k indexed citations. Recurring topics across this work include PI3K/AKT/mTOR signaling in cancer (19 papers), Chemokine receptors and signaling (10 papers) and Immunotherapy and Immune Responses (9 papers). The work is most often cited by research in Oncology (834 citations), Cancer Research (368 citations) and Endocrinology, Diabetes and Metabolism (295 citations). Benjamin D.�L. Li has collaborated with scholars based in United States, China and Czechia. Frequent co-authors include Quyen D. Chu, Arrigo De Benedetti, Herbert Yu, Lester W. Johnson, Carol Meschonat, Fleurette Abreo, Hans J. Berkel, Roger H. Kim, John C. McDonald and Li Liu. Their work appears in journals such as Cancer, Cancer Research and Annals of Surgery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.